Microbiome - Epigenome interactions and the environmental origins of inflammatory bowel diseases

Journal of Pediatric Gastroenterology and Nutrition

Volumn 62, Issue 2, 2016, Pages 208-219

  Fofanova, Tatiana Y ^a,b   Petrosino, Joseph F ^a,c   Kellermayer, Richard ^d  

^a Alkek Center for Metagenomics and Microbiome Research   (United States)

^b Program in Translational Biology and Molecular Medicine   (United States)

^c Department of Molecular Virology and Microbiology ^*  (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Crohn disease; Developmental origins; DNA methylation; Environment; Epidemiology; Inflammatory bowel disease; Microbiome; Nutrition; Ulcerative colitis

Indexed keywords

BUTYRIC ACID; ELEMENT; POLYUNSATURATED FATTY ACID;

COMMENSALISM; CROHN DISEASE; DEVELOPMENTAL BIOLOGY; DNA METHYLATION; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; EPIGENETICS; GENE INTERACTION; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HOST; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; MICROBIOLOGICAL EXAMINATION; MICROBIOME; MIGRANT; MONOZYGOTIC TWINS; NONHUMAN; NUTRITIONAL STATUS; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; ULCERATIVE COLITIS; BACTERIUM; DIET; ENVIRONMENT; GENETIC EPIGENESIS; GENETICS; GENOME; INFLAMMATORY BOWEL DISEASES; MICROBIOLOGY; MICROFLORA;

BACTERIA; DIET; DNA METHYLATION; ENVIRONMENT; EPIGENESIS, GENETIC; GENOME; HUMANS; INFLAMMATORY BOWEL DISEASES; MICROBIOTA;

EID: 84957051182     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000950     Document Type: Review

References (222)

1. Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol 2014; 14: 329-42.
2. Ventham NT, Kennedy NA, Nimmo ER, et al. Beyond gene discovery in inflammatory bowel disease: the emerging role of epigenetics. Gastroenterology 2013; 145: 293-308.
3. Ruel J, Ruane D, Mehandru S, et al. IBD across the age spectrum-is it the same disease? Nat Rev Gastroenterol Hepatol 2014; 11: 88-98.
4. El-Matary W, Moroz SP, Bernstein CN. Inflammatory bowel disease in children of Manitoba: 30 years' experience of a tertiary center. J Pediatr Gastroenterol Nutr 2014; 59: 763-6.
5. Benchimol EI, Fortinsky KJ, Gozdyra P, et al. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011; 17: 423-39.
6. Benchimol EI, Mack DR, Guttmann A, et al. Inflammatory bowel disease in immigrants to Canada and their children: a population-based cohort study. Am J Gastroenterol 2015; 110: 553-63.
7. Kellermayer R. Epigenetics and the developmental origins of inflammatory bowel diseases. Can J Gastroenterol 2012; 26: 909-15.
8. Ponder A, Long MD. A clinical review of recent findings in the epidemiology of inflammatory bowel disease. Clin Epidemiol 2013; 5: 237-47.
9. Aujnarain A, Mack DR, Benchimol EI. The role of the environment in the development of pediatric inflammatory bowel disease. Curr Gastroenterol Rep 2013; 15: 326.
10. Parente JML. Inflammatory bowel disease in an underdeveloped region of Northeastern Brazil. World J Gastroenterol 2015; 21: 1197.
11. Ng SC, Bernstein CN, Vatn MH, et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut 2013; 62: 630-49.
12. Adamiak T, Walkiewicz-Jedrzejczak D, Fish D, et al. Incidence, clinical characteristics, and natural history of pediatric IBD in Wisconsin: a population-based epidemiological study. Inflamm Bowel Dis 2013; 19: 1218-23.
13. Lakatos L, Kiss LS, David G, et al. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002-2006. Inflamm Bowel Dis 2011; 17: 2558-65.
14. Gheorghe C, Pascu O, Gheorghe L, et al. Epidemiology of inflammatory bowel disease in adults who refer to gastroenterology care in Romania: a multicentre study. Eur J Gastroenterol Hepatol 2004; 16: 1153-9.
15. Burisch J, Munkholm P. The epidemiology of inflammatory bowel disease. Scand J Gastroenterol 2015; 50: 942-51.
16. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol 2006; 101: 1559-68.
17. Schultz M, Butt AG. Is the north to south gradient in inflammatory bowel disease a global phenomenon? Expert Rev Gastroenterol Hepatol 2012; 6: 445-7.
18. Burisch J, Munkholm P. Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol 2013; 29: 357-62.
19. Holmes EA, Xiang F, Lucas RM. Variation in incidence of pediatric Crohn's disease in relation to latitude and ambient ultraviolet radiation. Inflamm Bowel Dis 2015; 21: 809-17.
20. Nagy-Szakal D, Mir SA, Harris RA, et al. Loss of n-6 fatty acid induced pediatric obesity protects against acute murine colitis. FASEB J 2015; 29: 3151-9.
21. Forbes A, Kalantzis T. Crohn's disease: the cold chain hypothesis. Int J Colorectal Dis 2006; 21: 399-401.
22. Nagy-Szakal D, Mir SAV, Ross MC, et al. Monotonous diets protect against acute colitis in mice. J Pediatr Gastroenterol Nutr 2013; 56: 544-50.
23. David LA, Maurice CF, Carmody RN, et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 2014; 505: 559-63.
24. Nagy-Szakal D, Hollister EB, Luna RA, et al. Cellulose supplementation early in life ameliorates colitis in adult mice. PLoS One 2013; 8: e56685.
25. Suez J, Korem T, Zeevi D, et al. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 2014; 514: 181-6.
26. Chassaing B, Koren O, Goodrich JK, et al. Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome. Nature 2015; 519: 92-6.
27. Turnbaugh PJ, Ley RE, Mahowald Ma, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444: 1027-31.
28. Nagy-Szakal D, Ross MC, Dowd SE, et al. Maternal micronutrients can modify colonic mucosal microbiota maturation in murine offspring. Gut Microbes 2012; 3: 426-33.
29. Mir Sa, Nagy-Szakal D, Dowd SE, et al. Prenatal methyl-donor supplementation augments colitis in young adult mice. PLoS One 2013; 8: e73162.
30. Voisin S, Almén MS, Moschonis G, et al. Dietary fat quality impacts genome-wide DNA methylation patterns in a cross-sectional study of Greek preadolescents. Eur J Hum Genet 2014: 1-9.
31. Schaible TD, Harris RA, Dowd SE, et al. Maternal methyl-donor supplementation induces prolonged murine offspring colitis susceptibility in association with mucosal epigenetic and microbiomic changes. Hum Mol Genet 2011; 20: 1687-96.
32. Heijmans BT, Tobi EW, Stein AD, et al. Persistent epigenetic differences associated with prenatal exposure to famine in humans. Proc Natl Acad Sci U S A 2008; 105: 17046-9.
33. Chu KM, Watermeyer G, Shelly L, et al. Childhood helminth exposure is protective against inflammatory bowel disease: a case control study in South Africa. Inflamm Bowel Dis 2013; 19: 614-20.
34. Weinstock JV, Elliott DE. Helminths and the IBD hygiene hypothesis. Inflamm Bowel Dis 2009; 15: 128-33.
35. Broadhurst MJ, Ardeshir A, Kanwar B, et al. Therapeutic helminth infection of macaques with idiopathic chronic diarrhea alters the inflammatory signature and mucosal microbiota of the colon. PLoS Pathog 2012; 8: e1003000.
36. Lee SC, Tang MS, Lim YAL, et al. Helminth colonization is associated with increased diversity of the gut microbiota. PLoS Negl Trop Dis 2014; 8: e2880.
37. Deaton AM, Cook PC, De Sousa D, et al. A unique DNA methylation signature defines a population of IFN-g/IL-4 double-positive T cells during helminth infection. Eur J Immunol 2014; 44: 1835-41.
38. Rodríguez LAG, Ruigómez A, Panés J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 2006; 130: 1588-94.
39. Virta L, Auvinen A, Helenius H, et al. Association of repeated exposure to antibiotics with the development of pediatric crohn's disease-a nationwide, register-based Finnish case-control study. Am J Epidemiol 2012; 175: 775-84.
40. Porter CK, Tribble DR, Aliaga PA, et al. Infectious gastroenteritis and risk of developing inflammatory bowel disease. Gastroenterology 2008; 135: 781-6.
41. Green C, Elliott L, Beaudoin C, et al. A population-based ecologic study of inflammatory bowel disease: Searching for etiologic clues. Am J Epidemiol 2006; 164: 615-23.
42. Modi SR, Collins JJ, Relman DA. Antibiotics and the gut microbiota. J Clin Invest 2014; 124: 4212-8.
43. Zeh JA, Bonilla MM, Adrian AJ, et al. From father to son: transgenerational effect of tetracycline on sperm viability. Sci Rep 2012; 2: 375.
44. Munyaka PM, Khafipour E, Ghia J-E. External influence of early childhood establishment of gut microbiota and subsequent health implications. Front Pediatr 2014; 2: 1-9.
45. Soon IS, Molodecky NA, Rabi DM, et al. The relationship between urban environment and the inflammatory bowel diseases: a systematic review and meta-analysis. BMC Gastroenterol 2012; 12: 51.
46. Castiglione F, Diaferia M, Morace F, et al. Risk factors for inflammatory bowel diseases according to the "hygiene hypothesis": a casecontrol, multi-centre, prospective study in Southern Italy. J Crohns Colitis 2012; 6: 324-9.
47. Timm S, Svanes C, Janson C, et al. Place of upbringing in early childhood as related to inflammatory bowel diseases in adulthood: a population-based cohort study in Northern Europe. Eur J Epidemiol 2014; 29: 429-37.
48. Kaplan GG, Hubbard J, Korzenik J, et al. The inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterol 2010; 105: 2412-9.
49. Ananthakrishnan AN, McGinley EL, Binion DG, et al. Ambient air pollution correlates with hospitalizations for inflammatory bowel disease: an ecologic analysis. Inflamm Bowel Dis 2011; 17: 1138-45.
50. Tyakht AV, Kostryukova ES, Popenko AS, et al. Human gut microbiota community structures in urban and rural populations in Russia. Nat Commun 2013; 4: 2469.
51. Tyakht AV, Alexeev DG, Popenko AS, et al. Rural and urban microbiota. Gut Microbes 2014; 5: 351-6.
52. Boyko EJ, Perera DR, Koepsell TD, et al. Effects of cigarette smoking on the clinical course of ulcerative colitis. Scand J Gastroenterol 1988; 23: 1147-52.
53. Calabrese E, Yanai H, Shuster D, et al. Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis. J Crohn's Colitis 2012; 6: 756-62.
54. Beaugerie L, Massot N, Carbonnel F, et al. Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol 2001; 96: 2113-6.
55. Van der Heide F, Dijkstra A, Weersma RK, et al. Effects of active and passive smoking on disease course of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2009; 15: 1199-207.
56. Cosnes J, Beaugerie L, Carbonnel F, et al. Smoking cessation and the course of Crohn's disease: an intervention study. Gastroenterology 2001; 120: 1093-9.
57. Seksik P, Nion-Larmurier I, Sokol H, et al. Effects of light smoking consumption on the clinical course of Crohn's disease. Inflamm Bowel Dis 2009; 15: 734-41.
58. Biedermann L, Zeitz J, Mwinyi J, et al. Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans. PLoS One 2013: 8.
59. Biedermann L, Brulisauer K, Zeitz J, et al. Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH. Inflamm Bowel Dis 2014; 20: 1496-501.
60. Benjamin JL, Hedin CRH, Koutsoumpas A, et al. Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm Bowel Dis 2012; 18: 1092-100.
61. Breton CV, Byun HM, Wenten M, et al. Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation. Am J Respir Crit Care Med 2009; 180: 462-7.
62. Guerrero-Preston R, Goldman LR, Brebi-Mieville P, et al. Global DNA hypomethylation is associated with in utero exposure to cotinine and perfluorinated alkyl compounds. Epigenetics 2010; 5: 539-46.
63. Lee KWK, Pausova Z. Cigarette smoking and DNA methylation. Front Genet 2013; 4: 132.
64. Drake AJ, Shaughnessy PJO, Bhattacharya S, et al. In utero exposure to cigarette chemicals induces sex-specific disruption of one-carbon metabolism and DNA methylation in the human fetal liver. BMC Med 2015; 13: 1-12.
65. Novakovic B, Ryan J, Pereira N, et al. Postnatal stability and tissueand time-specific effects of AHRR methylation change in response to maternal smoking in pregnancy. Epigenetics 2013; 9: 377-86.
66. Philibert Ra, Beach SRH, Lei M-K, et al. Changes in DNA methylation at the aryl hydrocarbon receptor repressor may be a new biomarker for smoking. Clin Epigenetics 2013; 5: 19.
67. Zhang Y, Yang R, Burwinkel B, et al. F2RL3 methylation as a biomarker of current and lifetime smoking exposures. Environ Health Perspect 2014; 122: 131-7.
68. Zeilinger S, Kühnel B, Klopp N, et al. Tobacco smoking leads to extensive genome-wide changes in DNA methylation. PLoS One 2013: 8.
69. Sonntag B, Stolze B, Heinecke A, et al. Preterm birth but not mode of delivery is associated with an increased risk of developing inflammatory bowel disease later in life. Inflamm Bowel Dis 2007; 13: 1385-90.
70. Gritz EC, Bhandari V. The human neonatal gut microbiome: a brief review. Front Pediatr 2015; 3: 17.
71. Cruickshank MN, Oshlack A, Theda C, et al. Analysis of epigenetic changes in survivors of preterm birth reveals the effect of gestational age and evidence for a long-term legacy. Genome Med 2013; 5: 96.
72. Kuss SK, Best GT, Etheredge CA, et al. Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science 2011; 334: 249-52.
73. Robinson CM, Jesudhasan PR, Pfeiffer JK. Bacterial lipopolysaccharide binding enhances virion stability and promotes environmental fitness of an enteric virus. Cell Host Microbe 2014; 15: 36-46.
74. Juste RA, Elguezabal N, Pavón A, et al. Association between Mycobacterium avium subsp. paratuberculosis DNA in blood and cellular and humoral immune response in inflammatory bowel disease patients and controls. Int J Infect Dis 2009; 13: 247-54.
75. Lee A, Griffiths TA, Parab RS, et al. Association of Mycobacterium avium subspecies paratuberculosis with Crohn Disease in pediatric patients. J Pediatr Gastroenterol Nutr 2011; 52: 170-4.
76. Kirkwood CD, Wagner J, Boniface K, et al. Mycobacterium avium subspecies paratuberculosis in children with early-onset Crohn's disease. Inflamm Bowel Dis 2009; 15: 1643-55.
77. Pennini ME, Pai RK, Schultz DC, et al. Mycobacterium tuberculosis 19-kDa lipoprotein inhibits IFN-gamma-induced chromatin remodeling of MHC2TA by TLR2 and MAPK signaling. J Immunol 2006; 176: 4323-30.
78. Gardenbroek TJ, Eshuis EJ, Ponsioen CIJ, et al. The effect of appendectomy on the course of ulcerative colitis: a systematic review. Colorectal Dis 2012; 14: 545-53.
79. Radford-Smith GL, Edwards JE, Purdie DM, et al. Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease. Gut 2002; 51: 808-13.
80. Russel MG, Dorant E, Brummer RJ, et al. Appendectomy and the risk of developing ulcerative colitis or Crohn's disease: results of a large case-control study. South Limburg Inflammatory Bowel Disease Study Group. Gastroenterology 1997; 113: 377-82.
81. López-Serrano P, Pérez-Calle JL, Pérez-Fernández MT, et al. Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: a Spanish case-control study. Scand J Gastroenterol 2010; 45: 1464-71.
82. Reif S, Lavy A, Keter D, et al. Appendectomy is more frequent but not a risk factor in Crohn's disease while being protective in ulcerative colitis: a comparison of surgical procedures in inflammatory bowel disease. Am J Gastroenterol 2001; 96: 829-32.
83. Jackson HT, Mongodin EF, Davenport KP, et al. Culture-independent evaluation of the appendix and rectum microbiomes in children with and without appendicitis. PLoS One 2014; 9: e95414.
84. Barclay AR, Russell RK, Wilson ML, et al. Systematic review: the role of breastfeeding in the development of pediatric inflammatory bowel disease. J Pediatr 2009; 155: 421-6.
85. Rogier EW, Frantz AL, Bruno MEC, et al. Secretory antibodies in breast milk promote long-term intestinal homeostasis by regulating the gut microbiota and host gene expression. Proc Natl Acad Sci U S A 2014; 111: 3074-9.
86. Thompson AL, Monteagudo-Mera A, Cadenas MB, et al. Milk- and solid-feeding practices and daycare attendance are associated with differences in bacterial diversity, predominant communities, and metabolic and immune function of the infant gut microbiome. Front Cell Infect Microbiol 2015; 5: 1-15.
87. Sävendahl L, Underwood LE, Haldeman KM, et al. Fasting prevents experimental murine colitis produced by dextran sulfate sodium and decreases interleukin-1beta and insulin-like growth factor I messenger ribonucleic acid. Endocrinology 1997; 138: 734-40.
88. Singh UP, Singh NP, Guan H, et al. The emerging role of leptin antagonist as potential therapeutic option for inflammatory bowel disease. Int Rev Immunol 2014; 33: 23-33.
89. Matarese G, La Cava A, Sanna V, et al. Balancing susceptibility to infection and autoimmunity: a role for leptin? Trends Immunol 2002; 23: 182-7.
90. Barbier M, Cherbut C, Aubé AC, et al. Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats. Gut 1998; 43: 783-90.
91. Siegmund B, Lehr HA, Fantuzzi G. Leptin: a pivotal mediator of intestinal inflammation in mice. Gastroenterology 2002; 122: 2011-25.
92. De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 2010; 107: 14691-6.
93. Kohl KD, Amaya J, Passement CA, et al. Unique and shared responses of the gut microbiota to prolonged fasting: a comparative study across five classes of vertebrate hosts. FEMS Microbiol Ecol 2014; 90: 883-94.
94. Damms-Machado A, Mitra S, Schollenberger AE, et al. Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. Biomed Res Int 2015; 2015: 806248.
95. Zhang C, Li S, Yang L, et al. Structural modulation of gut microbiota in life-long calorie-restricted mice. Nat Commun 2013; 4: 2163.
96. Tobi EW, Goeman JJ, Monajemi R, et al. DNA methylation signatures link prenatal famine exposure to growth and metabolism. Nat Commun 2014; 5: 5592.
97. Dominguez-Salas P, Moore SE, Baker MS, et al. Maternal nutrition at conception modulates DNA methylation of human metastable epialleles. Nat Commun 2014; 5: 3746.
98. Hughes LAE, van den Brandt PA, de Bruïne AP, et al. Early life exposure to famine and colorectal cancer risk: a role for epigenetic mechanisms. PLoS One 2009; 4: e7951.
99. Ananthakrishnan AN, Khalili H, Konijeti GG, et al. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut 2014; 63: 776-84.
100. Goldsmith JR, Sartor RB. The role of diet on intestinal microbiota metabolism: downstream impacts on host immune function and health, and therapeutic implications. J Gastroenterol 2014; 49: 785-98.
101. Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol 2011; 106: 563-73.
102. Paparo L, di Costanzo M, di Scala C, et al. The influence of early life nutrition on epigenetic regulatory mechanisms of the immune system. Nutrients 2014; 6: 4706-19.
103. Johnson IT, Belshaw NJ. The effect of diet on the intestinal epigenome. Epigenomics 2014; 6: 239-51.
104. Andersen V, Olsen A, Carbonnel F, et al. Diet and risk of inflammatory bowel disease. Dig Liver Dis 2012; 44: 185-94.
105. Ooi JH, Li Y, Rogers CJ, et al. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J Nutr 2013; 143: 1679-86.
106. Ananthakrishnan AN, Cagan A, Gainer VS, et al. Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases. Aliment Pharmacol Ther 2014; 39: 1136-42.
107. Sahay T, Ananthakrishnan AN. Vitamin D deficiency is associated with community-acquired Clostridium difficile infection: a case-control study. BMC Infect Dis 2014; 14: 661.
108. Yu S, Cantorna MT. Epigenetic reduction in invariant NKT cells following in utero vitamin D deficiency in mice. J Immunol 2011; 186: 1384-90.
109. Sonnenberg A, Melton SD, Genta RM, et al. Absence of focally enhanced gastritis in macaques with idiopathic colitis. Inflamm Bowel Dis 2011; 17: 2456-61.
110. Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature 2010; 465: 721-7.
111. Tjonneland A, Overvad K, Bergmann MM, et al. Linoleic acid, a dietary n-6 polyunsaturated fatty acid, and the aetiology of ulcerative colitis: a nested case-control study within a European prospective cohort study. Gut 2009; 58: 1606-11.
112. Octoratou M, Merikas E, Malgarinos G, et al. A prospective study of pre-illness diet in newly diagnosed patients with Crohn's disease. Rev Med Chir Soc Med Nat Las?i 2016; 116: 40-9.
113. Iablokov V, Sydora BC, Foshaug R, et al. Naturally occurring glycoalkaloids in potatoes aggravate intestinal inflammation in two mouse models of inflammatory bowel disease. Dig Dis Sci 2010; 55: 3078-85.
114. Hugot J-P, Alberti C, Berrebi D, et al. Crohn's disease: the cold chain hypothesis. Lancet 2003; 362: 2012-5.
115. Goudie A, Cuff D, eds. Encyclopedia of Global Change. New York: Oxford University Press; 2005.
116. Maslowski KM, Vieira AT, Ng A, et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009; 461: 1282-6.
117. Atarashi K, Tanoue T, Shima T, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science 2011; 331: 337-41.
118. Olszak T, An D, Zeissig S, et al. Microbial exposure during early life has persistent effects on natural killer T cell function. Science 2012; 336: 489-93.
119. Barreiro-de Acosta M, Alvarez Castro A, Souto R, et al. Emigration to western industrialized countries: a risk factor for developing inflammatory bowel disease. J Crohns Colitis 2011; 5: 566-9.
120. Li X, Sundquist J, Hemminki K, et al. Risk of inflammatory bowel disease in first- and second-generation immigrants in Sweden: A nationwide follow-up study. Inflamm Bowel Dis 2011; 17: 1784-91.
121. Pinsk V, Lemberg DA, Grewal K, et al. Inflammatory bowel disease in the South Asian pediatric population of British Columbia. Am J Gastroenterol 2007; 102: 1077-83.
122. Jostins L, Ripke S, Weersma RK, et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-24.
123. Guo Q-S, Xia B, Jiang Y, et al. NOD2 3020insC frameshift mutation is not associated with inflammatory bowel disease in Chinese patients of Han nationality. World J Gastroenterol 2004; 10: 1069-71.
124. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology 2002; 123: 86-91.
125. Ozen SC, Dagli U, Kiliç MY, et al. NOD2/CARD15, NOD1/CARD4, and ICAM-1 gene polymorphisms in Turkish patients with inflammatory bowel disease. J Gastroenterol 2006; 41: 304-10.
126. Juyal G, Prasad P, Senapati S, et al. An investigation of genome-wide studies reported susceptibility loci for ulcerative colitis shows limited replication in north Indians. PLoS One 2011; 6: e16565.
127. Wei S-C, Tan Y-Y, Weng M-T, et al. SLCO3A1, A novel Crohn's disease-associated gene, regulates NF-kB activity and associates with intestinal perforation. PLoS One 2014; 9: e100515.
128. Brant SR. Update on the heritability of inflammatory bowel disease: the importance of twin studies. Inflamm Bowel Dis 2011; 17: 1-5.
129. Kellermayer R, Genetic drift. Physiologic noise obscures genotypephenotype correlations. Am J Med Genet A 2007; 143A: 1306-7.
130. Sejdić E, Lipsitz LA. Necessity of noise in physiology and medicine. Comput Methods Programs Biomed 2013; 111: 459-70.
131. Kellermayer R. "Omics" as the filtering gateway between environment and phenotype: the inflammatory bowel diseases example. Am J Med Genet Part A 2010; 152A: 3022-5.
132. Petrosino JF, Highlander S, Luna RA, et al. Metagenomic pyrosequencing and microbial identification. Clin Chem 2009; 55: 856-66.
133. Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature 2007; 449: 804-10.
134. Clemente JC, Ursell LK, Parfrey LW, et al. The impact of the gut microbiota on human health: an integrative view. Cell 2012; 148: 1258-70.
135. Peterson J, Garges S, Giovanni M, et al. The NIH human microbiome project. Genome Res 2009; 19: 2317-23.
136. Gevers D, Kugathasan S, Denson LA, et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 2014; 15: 382-92.
137. Morgan XC, Tickle TL, Sokol H, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 2012; 13: R79.
138. Fava F, Danese S. Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol 2011; 17: 557-66.
139. Geremia A, Biancheri P, Allan P, et al. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev 2014; 13: 3-10.
140. Bruewer M, Luegering A, Kucharzik T, et al. Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms. J Immunol 2003; 171: 6164-72.
141. Rieder F, Schleder S, Wolf A, et al. Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior. Inflamm Bowel Dis 2010; 16: 263-74.
142. Russell RK, Ip B, Aldhous MC, et al. Anti-Saccharomyces cerevisiae antibodies status is associatedwith oral involvement and disease severity in Crohn disease. J Pediatr Gastroenterol Nutr 2009; 48: 161-7.
143. Alenghat T, Osborne LC, Saenz Sa, et al. Histone deacetylase 3 coordinates commensal-bacteria-dependent intestinal homeostasis. Nature 2013; 504: 153-7.
144. Yatsunenko T, Rey FE, Manary MJ, et al. Human gut microbiome viewed across age and geography. Nature 2012; 486: 222-7.
145. Kellermayer R. Burdening questions about Clostridium difficile in pediatric inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 2015; 60: 421-2.
146. Faith JJ, Guruge JL, Charbonneau M, et al. The long-term stability of the human gut microbiota. Science 2013; 341: 1237439.
147. Carmody RN, Gerber GK, Luevano JM, et al. Diet dominates host genotype in shaping the murine gut microbiota. Cell Host Microbe 2014; 17: 72-84.
148. Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334: 105-8.
149. Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012; 143: 913e7-6e7.
150. Borody TJ, Khoruts A. Fecal microbiota transplantation and emerging applications. Nat Rev Gastroenterol Hepatol 2012; 9: 88-96.
151. Kelly CR, Ihunnah C, Fischer M, et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol 2014; 109: 1065-71.
152. Weingarden AR, Chen C, Bobr A, et al. Microbiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection. Am J Physiol Gastrointest Liver Physiol 2014; 306: G310-9.
153. Martino D, Loke YJ, Gordon L, et al. Longitudinal, genome-scale analysis of DNA methylation in twins from birth to 18 months of age reveals rapid epigenetic change in early life and pair-specific effects of discordance. Genome Biol 2013; 14: R42.
154. Kellermayer R, Balasa A, Zhang W, et al. Epigenetic maturation in colonic mucosa continues beyond infancy in mice. Hum Mol Genet 2010; 19: 2168-76.
155. Waterland RA, Kellermayer R, Laritsky E, et al. Season of conception in rural gambia affects DNA methylation at putative human metastable epialleles. PLoS Genet 2010; 6: 1-10.
156. Cho CE, Pannia E, Huot PSP, et al. Methyl vitamins contribute to obesogenic effects of a high multivitamin gestational diet and epigenetic alterations in hypothalamic feeding pathways in Wistar rat offspring. Mol Nutr Food Res 2015; 59: 476-89.
157. Gao F, Zhang J, Jiang P, et al. Marked methylation changes in intestinal genes during the perinatal period of preterm neonates. BMC Genomics 2014; 15: 716.
158. Dauncey MJ. Recent advances in nutrition, genes and brain health. Proc Nutr Soc 2012; 71: 581-91.
159. Schnabel RB, Baccarelli A, Lin H, et al. Next steps in cardiovascular disease genomic research-sequencing, epigenetics, and transcriptomics. Clin Chem 2012; 58: 113-26.
160. Naguib M, Bie B, Ting AH. Fundamental concepts of epigenetics for consideration in anesthesiology. Curr Opin Anaesthesiol 2012; 25: 434-43.
161. Petronis A, Petroniene R. Epigenetics of inflammatory bowel disease. Gut 2000; 47: 302-6.
162. Scarpa M, Stylianou E. Epigenetics: concepts and relevance to IBD pathogenesis. Inflamm Bowel Dis 2012; 18: 1982-96.
163. Jenke AC, Zilbauer M. Epigenetics in inflammatory bowel disease. Curr Opin Gastroenterol 2012; 28: 577-84.
164. Rosen MJ, Frey MR, Washington MK, et al. STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction. Inflamm Bowel Dis 2011; 17: 2224-34.
165. Felice C, Lewis A, Armuzzi A, et al. Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases. Aliment Pharmacol Ther 2015; 41: 26-38.
166. Wu F, Guo NJ, Tian H, et al. Peripheral blood MicroRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 2011; 17: 241-50.
167. ChenY, GeW, Xu L, et al. miR-200b is involved in intestinal fibrosis of Crohn's disease. Int J Mol Med 2012; 29: 601-6.
168. Zahm AM, Thayu M, Hand NJ, et al. Circulating MicroRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2011; 53: 26-33.
169. Koukos G, Polytarchou C, Kaplan JL, et al. A MicroRNA signature in pediatric ulcerative colitis: deregulation of the miR-4284/CXCL5 pathway in the intestinal epithelium. Inflamm Bowel Dis 2015; 21: 996-1005.
170. Wigler M, Levy D, Perucho M. The somatic replication of DNA methylation. Cell 1981; 24: 33-40.
171. Margueron R, Reinberg D. Chromatin structure and the inheritance of epigenetic information. Nat Rev Genet 2010; 11: 285-96.
172. Faulk C, Dolinoy DC. Timing is everything: the when and how of environmentally induced changes in the epigenome of animals. Epigenetics 2011; 6: 791-7.
173. Adams AT, Kennedy Na, Hansen R, et al. Two-stage genome-wide methylation profiling in childhood-onset Crohn's disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci. Inflamm Bowel Dis 2014; 0: 1-10.
174. Harris RA, Nagy-Szakal D, Pedersen N, et al. Genome-wide peripheral blood leukocyte DNA methylation microarrays identified a single association with inflammatory bowel diseases. Inflamm Bowel Dis 2012; 18: 2334-41.
175. Kellermayer R. Hurdles for epigenetic disease associations from peripheral blood leukocytes. Inflamm Bowel Dis 2013; 19: E66-7.
176. Saito S, Kato J, Hiraoka S, et al. DNA methylation of colon mucosa in ulcerative colitis patients: correlation with inflammatory status. Inflamm Bowel Dis 2011; 17: 1955-65.
177. Lin Z, Hegarty JP, Cappel JA, et al. Identification of disease-associated DNA methylation in intestinal tissues from patients with inflammatory bowel disease. Clin Genet 2011; 80: 59-67.
178. Yuan B, Zhang J, Wang H, et al. 6-Thioguanine reactivates epigenetically silenced genes in acute lymphoblastic leukemia cells by facilitating proteasome-mediated degradation of DNMT. Cancer Res 2011; 71: 1904-11.
179. Harris RA, Nagy-Szakal D, Mir SAV, et al. DNA methylation-associated colonic mucosal immune and defense responses in treatmentnaïve pediatric ulcerative colitis. Epigenetics 2014; 9: 1131-7.
180. Häsler R, Feng Z, Bäckdahl L, et al. A functional methylome map of ulcerative colitis. Genome Res 2012; 22: 2130-7.
181. Alenghat T. Epigenomics and the microbiota. Toxicol Pathol 2015; 43: 101-6.
182. Salvucci E. Microbiome, holobiont and the net of life. Crit Rev Microbiol 2014; 28: 1-10.
183. Bierne H, Hamon M, Cossart P. Epigenetics and bacterial infections. Cold Spring Harb Perspect Med 2012; 2: a010272.
184. Tolg C, Sabha N, Cortese R, et al. Uropathogenic E. coli infection provokes epigenetic downregulation of CDKN2A (p16INK4A) in uroepithelial cells. Lab Invest 2011; 91: 825-36.
185. Chernov AV, Reyes L, Xu Z, et al. Mycoplasma CG- and GATCspecific DNA methyltransferases selectively and efficiently methylate the host genome and alter the epigenetic landscape in human cells. Epigenetics 2015; 10: 303-18.
186. Shenderov BA. Gut indigenous microbiota and epigenetics. Microb Ecol Health Dis 2012; 23: 1-6.
187. Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 2009; 294: 1-8.
188. Lopez-Siles M, Martinez-Medina M, Busquets D, et al. Mucosaassociated Faecalibacterium prausnitzii and Escherichia coli coabundance can distinguish irritable bowel syndrome and inflammatory bowel disease phenotypes. Int J Med Microbiol 2014; 304: 464-75.
189. Wang W, Chen L, Zhou R, et al. Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease. J Clin Microbiol 2014; 52: 398-406.
190. Machiels K, Joossens M, Sabino J, et al. A decrease of the butyrateproducing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 2014; 63: 1275-83.
191. Cao Y, Shen J, Ran ZH. Association between Faecalibacterium prausnitzii reduction and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Gastroenterol Res Pract 2014; 2014: 872725.
192. Fujimoto T, Imaeda H, Takahashi K, et al. Decreased abundance of Faecalibacterium prausnitzii in the gut microbiota of Crohn's disease. J Gastroenterol Hepatol 2013; 28: 613-9.
193. Hamer HM, Jonkers D, Venema K, et al. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther 2008; 27: 104-19.
194. Berni Canani R, Di Costanzo M, Leone L. The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clin Epigenetics 2012; 4: 4.
195. Mali P, Chou BK, Yen J, et al. Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes. Stem Cells 2010; 28: 713-20.
196. Kumar A, Wu H, Collier-Hyams LS, et al. The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen species-mediated changes in cullin-1 neddylation. J Immunol 2009; 182: 538-46.
197. Boesmans L, Ramakers M, Arijs I, et al. Inflammation-induced downregulation of butyrate uptake and oxidation is not caused by a reduced gene expression. J Cell Physiol 2014: 1-31.
198. De Preter V, Arijs I, Windey K, et al. Impaired butyrate oxidation in ulcerative colitis is due to decreased butyrate uptake and a defect in the oxidation pathway. Inflamm Bowel Dis 2012; 18: 1127-36.
199. Santhanam S, Venkatraman A, Ramakrishna BS. Impairment of mitochondrial acetoacetyl CoA thiolase activity in the colonic mucosa of patients with ulcerative colitis. Gut 2007; 56: 1543-9.
200. Thibault R, Blachier F, Darcy-Vrillon B, et al. Butyrate utilization by the colonic mucosa in inflammatory bowel diseases. Inflamm Bowel Dis 2010; 16: 684-95.
201. Vernia P, Annese V, Bresci G, et al. Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial. Eur J Clin Invest 2003; 33: 244-8.
202. Rossi M, Amaretti A, Raimondi S. Folate production by probiotic bacteria. Nutrients 2011; 3: 118-34.
203. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology 2008; 134: 577-94.
204. Chassaing B, Darfeuillemichaud A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 2011; 140: 1720-8.
205. Mazmanian SK, Round JL, Kasper DL. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008; 453: 620-5.
206. Nelson DB, Murdoch M, Sandozi IK, et al. Increased levels of homocysteine in patients with Crohn's disease are related to folate levels. Am J Gastroenterol 2000; 95: 3498-502.
207. Heyman M, Garnett E. Folate concentrations in pediatric patients with newly diagnosed inflammatory bowel disease. Am J Clin Nutr 2009; 89: 545-50.
208. Alkhouri RH, Hashmi H, Baker RD, et al. Vitamin and mineral status in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2013; 56: 89-92.
209. Vagianos K, Bernstein CN. Homocysteinemia and B vitamin status among adult patients with inflammatory bowel disease: a one-year prospective follow-up study. Inflamm Bowel Dis 2012; 18: 718-24.
210. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci U S A 2002; 99: 15451-5.
211. Hill DA, Artis D. Intestinal bacteria and the regulation of immune cell homeostasis. Annu Rev Immunol 2010; 28: 623-67.
212. Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 2010; 10: 735-44.
213. Round JL, Mazmanian SK. Inducible Foxp3? regulatory T-cell development by a commensal bacterium of the intestinal microbiota. Proc Natl Acad Sci U S A 2010; 107: 12204-9.
214. Adkins B. Development of neonatal Th1/Th2 function. Int Rev Immunol 2000; 19: 157-71.
215. McLoughlin RM, Mills KHG. Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. J Allergy Clin Immunol 2011; 127: 1097-107.
216. Wang Y, Devkota S, Musch MW, et al. Regional mucosa-associated microbiota determine physiological expression of TLR2 and TLR4 in murine colon. PLoS One 2010; 5: e13607.
217. Takahashi K, Sugi Y, Nakano K, et al. Epigenetic control of the host gene by commensal bacteria in large intestinal epithelial cells. J Biol Chem 2011; 286: 35755-62.
218. Takahashi K, Sugi Y, Hosono A, et al. Epigenetic regulation of TLR4 gene expression in intestinal epithelial cells for the maintenance of intestinal homeostasis. J Immunol 2009; 183: 6522-9.
219. Patel RM, Lin PW. Developmental biology of gut-probiotic interaction. Gut Microbes 2010; 1: 186-95.
220. Kumar H, Lund R, Laiho A, et al. Gut Microbiota as an epigenetic regulator: pilot study based on whole-genome methylation analysis. MBio 2014; 5: e02113-2114.
221. Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol 2010; 105: 2687-92.
222. Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis. Am J Gastroenterol 2011; 106: 2133-42.